Xbrane Biopharma AB (XBRANE) - Financial and Strategic SWOT Analysis Review

  • ID: 4278383
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • Xbrane Biopharma
1 of 4
Summary

Xbrane Biopharma AB (Xbrane), formerly known as Xbrane Bioscience AB, is a biopharmaceutical company that develops and manufactures complex generics. The company's product portfolio includes high demand biosimilars and long acting injectables developed for people suffering from critical diseases. It combines its proprietary microsphere and protein production technology platforms to develop and produce generics drugs for controlled release of the active substance through encapsulation in microspheres. The company’s products find application in treating diseases across various therapeutic areas including acromegaly and neuroendocrine tumours, prostate cancer, endometriosis and uterine fibroids; age-related macular degeneration and macular oedema and among others. Xbrane is headquartered in Stockholm, Sweden.

Xbrane Biopharma AB Key Recent Developments

Feb 28, 2018: Xbrane Biopharma releases year-end report for 2017
Dec 13, 2017: Xbrane Biopharma informs about changes in management team
Nov 13, 2017: Xbrane Biopharma releases interim report for the period July to September 2017
Oct 09, 2017: Xbrane Biopharma appoints Dina Jurman, Head of Clinical Affairs, to management team
Aug 31, 2017: Xbrane Biopharma Releases Interim Report for the Period April - June 2017

This comprehensive SWOT profile of Xbrane Biopharma AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xbrane Biopharma AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Xbrane Biopharma AB - Key Information
  • Xbrane Biopharma AB - Overview
  • Xbrane Biopharma AB - Key Employees
  • Xbrane Biopharma AB - Key Employee Biographies
  • Xbrane Biopharma AB - Key Operational Heads
  • Xbrane Biopharma AB - Major Products and Services
  • Xbrane Biopharma AB - History
  • Xbrane Biopharma AB - Company Statement
  • Xbrane Biopharma AB - Locations And Subsidiaries
  • Xbrane Biopharma AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Xbrane Biopharma AB - Business Description
  • Xbrane Biopharma AB - Corporate Strategy
  • Xbrane Biopharma AB - SWOT Analysis
  • SWOT Analysis - Overview
  • Xbrane Biopharma AB - Strengths
  • Xbrane Biopharma AB - Weaknesses
  • Xbrane Biopharma AB - Opportunities
  • Xbrane Biopharma AB - Threats
  • Xbrane Biopharma AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • Xbrane Biopharma AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Xbrane Biopharma AB, Key Information
  • Xbrane Biopharma AB, Key Ratios
  • Xbrane Biopharma AB, Share Data
  • Xbrane Biopharma AB, Major Products and Services
  • Xbrane Biopharma AB, History
  • Xbrane Biopharma AB, Key Employees
  • Xbrane Biopharma AB, Key Employee Biographies
  • Xbrane Biopharma AB, Key Operational Heads
  • Xbrane Biopharma AB, Other Locations
  • Xbrane Biopharma AB, Subsidiaries
  • Xbrane Biopharma AB, Key Manufacturing facilities
  • Xbrane Biopharma AB, Key Competitors
  • Xbrane Biopharma AB, SWOT Analysis
  • Xbrane Biopharma AB, Ratios based on current share price
  • Xbrane Biopharma AB, Annual Ratios
  • Xbrane Biopharma AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Xbrane Biopharma AB, Performance Chart
  • Xbrane Biopharma AB, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll